Our study also intended to evaluate the regulatory role of metabolic effectors (glucose, insulin, GLP-1 and butyrate) on DPP-4 expression in osteoblasts derived from AIS and control subjects. This evidence concerns the gene INS and androgen insensitivity syndrome.